The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children.
about
Fresh frozen plasma for cardiovascular surgeryPlasma transfusions prior to insertion of central lines for patients with abnormal coagulationPro-coagulant haemostatic factors for the prevention and treatment of bleeding in patients without haemophiliaProphylactic plasma and platelet transfusion in the critically Ill patient: just useless and expensive or even harmful?Evidence and triggers for the transfusion of blood and blood productsA 2014 Update on Coagulation Management for Cardiopulmonary Bypass.Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME).Monitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease.The quality changes in fresh frozen plasma of the blood donors at high altitudeThe evaluation of enhanced feedback interventions to reduce unnecessary blood transfusions (AFFINITIE): protocol for two linked cluster randomised factorial controlled trialsIs fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials.Improvements in patient blood management for pediatric craniosynostosis surgery using a ROTEM(®) -assisted strategy - feasibility and costsPlasma is ineffective in correcting mildly elevated PT-INR in critically ill children: a retrospective observational studyEffect of transfusion of fresh frozen plasma on parameters of endothelial condition and inflammatory status in non-bleeding critically ill patients: a prospective substudy of a randomized trial.A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.Risky Bodies in the Plasma Bioeconomy: A Feminist Analysis.Transfusion of fresh frozen plasma in non-bleeding ICU patients--TOPIC trial: study protocol for a randomized controlled trial.Adverse effects of plasma transfusionPlasma transfusions prior to insertion of central lines for people with abnormal coagulation.Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.Prophylactic plasma transfusion for surgical patients with abnormal preoperative coagulation tests: a single-institution propensity-adjusted cohort study.A multicenter study of plasma use in the United States.The evaluation of the audit of Fresh-Frozen Plasma (FFP) usage in emergency departmentThromboelastometry versus standard coagulation tests versus restrictive protocol to guide blood transfusion prior to central venous catheterization in cirrhosis: study protocol for a randomized controlled trial.Transfusion-related acute lung injury: a preventable syndrome?Plasma transfusion for bedside, radiologically guided, and operating room invasive procedures.How we decide when a neonate needs a transfusion.Epidural anaesthesia and analgesia for liver resection.Laboratory coagulation parameters in extremely premature infants born earlier than 27 gestational weeks upon admission to a neonatal intensive care unit.Use of plasma in the management of central nervous system bleeding: evidence-based consensus recommendations.Liver transplantation for acute liver failure: are there thresholds not to be crossed?Interpretation of clotting tests in the neonate.Activity-based costs of plasma transfusions in medical and surgical inpatients at a US hospital.Risk factors for bleeding after liver biopsy.Plasma Transfusion Demystified: A Review of the Key Factors Influencing the Response to Plasma Transfusion.Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study.Evaluation of a multi-center randomised clinical trial on prophylactic transfusion of fresh frozen plasma: implications for future trials.Abnormal coagulation tests before kidney biopsies-what next?Profiling clinical platelet and plasma use to inform blood supply and contingency planning: PUPPY, the prospective utilization of platelets and plasma study.Mathematical model and calculation to predict the effect of prophylactic plasma transfusion on change in international normalized ratio in critically ill patients with coagulopathy.
P2860
Q24186497-84672BF6-203E-4071-A96D-075618AAC2C1Q24187500-6382DB64-0A31-4BF4-B907-F75F7602C1C4Q24201587-74253210-E3C8-4F74-B047-8964CB775694Q27001075-2409052A-23CD-40AA-A76F-A3149AEC22FBQ27008573-5C53B9F5-F31C-4306-AC7D-8423EF056D78Q30458252-B7DB782D-AEBA-495A-89DB-B939143816BFQ33415825-2BF072A8-7412-4105-8333-AA0028E8F47BQ33435884-F108A735-7320-4042-A3C7-3B27C345AA01Q33590370-A8BF8F5A-CD86-46FF-8CB5-B334D1CC2AEAQ33868298-4AC6395F-C0EE-44C2-A060-34F705CF2870Q34132303-77A5EFB2-58B7-4D48-AF3D-CC962B8F9325Q34392304-E2216C22-E17E-409B-A800-E794C6AE17E3Q35106675-DC8FAC12-128E-438E-A40A-0D2D478A869CQ35531996-EE29D103-6555-4507-86C3-02A5B81E21C0Q35559573-15A94729-5DF7-43D1-A06D-E2F00816E66FQ35742103-CF8A0767-1957-4B41-BAA4-124DD7B7D31FQ35772078-4FF648F7-4F9F-47E7-B2A6-058C071FAF11Q35972184-F08314F7-E5D4-4986-BF1C-38784D7CFDDDQ36137840-8489F089-0D6D-4E2B-916B-688356335D6AQ36142046-F86E38DE-40D2-4C17-9661-630A9CD9890CQ36760558-43DF7BC8-A458-43EE-BAB0-A10BE84E094AQ37141692-EC176E12-6A08-49EF-92A0-BE40F337B2C4Q37499713-AE4E6307-D4AA-48EE-8B25-ABC4811B31C7Q37668195-F781A581-62A8-459F-A91A-D97D25C8F057Q37978345-BEE21AE2-9C99-4FA9-8FC7-F36DECE461A9Q38009414-031A4FDB-92E0-4883-A865-45B21AC3E295Q38055209-33C4ED0D-24E5-4004-9FFE-4D0082B6D47BQ38105593-25BC1354-302E-401B-BA99-CBD4B6C92811Q38136929-922AFAB7-48CF-4F4D-B760-9ECCFD5C062BQ38171401-6708E784-BC8B-40C7-8137-860AFD4E91FAQ38194205-2517039E-C3D6-4882-9E3E-24004A69B041Q38270155-4B6A5270-CB47-442B-B849-A8DCFAF35ADDQ38409495-9773A346-EE1B-4615-A426-BF9EAE02E06DQ38723525-0C3B791F-37E4-431F-916E-EE02A379D920Q38819188-C2DE1386-2172-4BF8-9C16-157325F02706Q39064863-F257AB3C-B6D2-474E-B75D-AB877A215FBEQ39132227-AB008454-A45F-4565-8215-987F0118D006Q39210509-92433C16-9848-4EE4-AB18-D28C19AB08C4Q39417906-451CF398-FFAA-4DB9-A104-D40AEB54B189Q40157879-07D640AC-1C00-47AA-A157-86DFB5E12EDE
P2860
The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
The use of fresh-frozen plasma ...... te use in adults and children.
@en
The use of fresh-frozen plasma ...... te use in adults and children.
@nl
type
label
The use of fresh-frozen plasma ...... te use in adults and children.
@en
The use of fresh-frozen plasma ...... te use in adults and children.
@nl
prefLabel
The use of fresh-frozen plasma ...... te use in adults and children.
@en
The use of fresh-frozen plasma ...... te use in adults and children.
@nl
P2093
P2860
P1433
P1476
The use of fresh-frozen plasma ...... te use in adults and children.
@en
P2093
Derek Lowe
John Grant-Casey
Mike F Murphy
Mike Laffan
Shubha Allard
Simon J Stanworth
P2860
P356
10.1111/J.1537-2995.2010.02798.X
P577
2010-08-27T00:00:00Z